For pharmaceutical CEOs: keep paused autoship subscribers engaged

CEOs see paused autoship subscribers drop out of recurring revenue, risking subscription churn. Add paused contacts to a win-back list so marketing can re-engage lapsed subscribers before churn.

For pharmaceutical CEOs: keep paused autoship subscribers engaged

Overview

Paused autoship subscribers quietly erode recurring revenue for pharmaceutical companies if marketing misses re-engagement windows. This workflow captures every paused contact into a win-back list and notifies marketing, turning passive churn into recoverable opportunities so manual follow-ups stop slipping through.

Notable Features

  • Add paused subscribers to win-back list
  • Tag contacts for targeted campaigns
  • Alert marketing about churn risk

For pharmaceutical CEOs: keep paused autoship subscribers engaged